Cite
HARVARD Citation
Rothenbuhler, A. et al. (2017). Two-year recombinant human growth hormone (rhGH) treatment is more effective in pre-pubertal compared to pubertal short children with X-linked hypophosphatemic rickets (XLHR). Growth hormone & IGF research. pp. 11-15. [Online].